Bear raid ugly today, but not unexpected. Bears pr

Bear raid ugly today, but not unexpected. Bears preying on the minds of investors who are getting jittery re no news. I too wish the company would update us more about the progress of the trial. I have another stock in phI open label and the CEO has chosen to give concrete info on each cohort participant. But Leo hasn't made that choice (and for phI open label it is a choice) and that's alright. We'll get there. I don't mind waiting until ASCO if that is his plan. I have read rumor of trial delay. It is a rumor based on a nonevent of final cohort 2 participant starting later than peers. There is no rule saying each participant in each cohort starts treatment at the same time. Though that is what the trial investigators would prefer, it just doesn't happen. People start after screening and acceptance and a single cohort can have participant start dates differ by weeks or even months. We won't see months difference in this trial as DF are master recruiters. But weeks would be expected and would also be a nonevent. This baby biotech meets all of the criteria of a great investment for the risk tolerant. Great management. Not a one trick pony - has promising pipeline. They manage their money well. They are respectful to shareholders. They have products that can appreciate sp dramatically. And their 2 lead products don't have to both win for us to win. We just need one and we will make a great profit. If we get both, we're rich.